Last updated 2025-02-12 19:42:26 (EST)

Quarterly Revenue Trend Analysis

Overall Quarterly Revenue Growth Trend of Healthcare Sector Companies.

Trend Chart of Adjusted Quarterly Revenue vs. Stock Price Trend Chart for Healthcare Sector ETF (XLV)
tooltip
Quarterly Revenue (USD) Price (USD)7,000,000,0008,000,000,0009,000,000,00010,000,000,00011,000,000,00012,000,000,00013,000,000,00014,000,000,00015,000,000,000204060801001201401601802017-01-012019-01-012021-01-012023-01-012025-02-12Seasonally Adjusted Quarterly RevenueQuarterly RevenuePrice

Seasonally Adjusted Quarterly Revenue Growth Rate tooltip

QoQ Growth Rate of Revenue3.7%
YoY Growth Rate of Revenue9.5%

Correlation Analysis between Quarterly Revenue and Stock Price

Determine the correlation between the stock price of the Healthcare Sector ETF (XLV) and the seasonally adjusted overall quarterly revenue of Healthcare sector companies. If there is a moderate to high correlation, the overall seasonally adjusted quarterly revenue can be used to estimate whether the stock price is reasonable.

Scatter Plot of Seasonally Adjusted Quarterly Revenue vs. Stock Price for Healthcare Sector
Price(USD)Seasonally Adjusted Quarterly Revenue (USD)54607080901001101201301401501607,195,693,0618,000,000,0009,000,000,00010,000,000,00011,000,000,00012,000,000,00013,000,000,00014,000,000,00015,000,000,000Linear RegressionHistorical Stock PricesCurrent Stock Price

Seasonally Adjusted Quarterly Revenue and stock price of Healthcare Sector show a High Correlation. The higher the correlation, the greater the reference value.

The Coefficient of Determination
between Seasonally Adjusted Quarterly Revenue and Stock Price

High Correlation 0.94

Related Stocks

Related Healthcare sector stocks, along with their quarterly revenue growth rates (QoQ and YoY).

Ticker Name QoQ Growth Rate of
Seasonally Adjusted
Quarterly Revenue
YoY Growth Rate of
Seasonally Adjusted
Quarterly Revenue
RETA
Reata Pharmaceuticals, Inc.
11302.5%2885%
BNTX
BioNTech SE
698.7%39%
MRNA
Moderna, Inc.
510.5%1.3%
MDGL
Madrigal Pharmaceuticals, Inc.
318.1%轉虧為盈%
ROIV
Roivant Sciences Ltd.
129.8%-75.7%
ITCI
Intra-Cellular Therapies, Inc.
75.2%39.2%
IMGN
ImmunoGen, Inc.
70%637.7%
BBIO
BridgeBio Pharma, Inc.
49.2%-33.2%
SRPT
Sarepta Therapeutics, Inc.
45%40.8%
GMAB
Genmab A/S
28%16.8%
HALO
Halozyme Therapeutics, Inc.
24.3%34.3%
ASND
Ascendis Pharma A/S
24%20.4%
OSH
Oak Street Health, Inc.
19.8%46.4%
NVO
Novo Nordisk A/S
15.2%30.1%
DHR
Danaher Corporation
12.5%142.8%
CORT
Corcept Therapeutics Incorporated
12.3%47.7%
TLX
Telix Pharmaceuticals Limited
11.9%55.7%
WST
West Pharmaceutical Services, Inc.
11.6%-0.1%
CI
Cigna Corporation
10.2%29.9%
SNY
Sanofi
9.6%11.5%
DOCS
Doximity, Inc.
9.4%24.6%
LLY
Eli Lilly and Company
9.2%44.7%
SNN
Smith & Nephew plc
9.1%8.7%
BMRN
BioMarin Pharmaceutical Inc.
9%27.3%
ISRG
Intuitive Surgical, Inc.
8.8%25.2%
SWAV
ShockWave Medical, Inc.
8.5%35.8%
RGEN
Repligen Corporation
7.4%9.7%
VRTX
Vertex Pharmaceuticals Incorporated
7.1%11.6%
NTRA
Natera, Inc.
6.9%63.9%
DGX
Quest Diagnostics Incorporated
6.7%14.6%
STVN
Stevanato Group S.p.A.
6.7%2.4%
MASI
Masimo Corporation
6.6%5.4%
WBA
Walgreens Boots Alliance, Inc.
5.9%7.5%
WAT
Waters Corporation
5.8%4%
CVS
CVS Health Corporation
5.6%6.3%
RDY
Dr. Reddy's Laboratories Limited
5.4%15.9%
HLN
Haleon plc
5.2%0.8%
ENSG
The Ensign Group, Inc.
5%15.5%
AZN
AstraZeneca PLC
4.9%23.8%
SYK
Stryker Corporation
4.3%10.7%
UTHR
United Therapeutics Corporation
4.3%22.9%
JAZZ
Jazz Pharmaceuticals plc
4.1%8.5%
MMSI
Merit Medical Systems, Inc.
3.9%7.8%
RPRX
Royalty Pharma plc
3.8%-0.3%
MDT
Medtronic plc
3.8%5.2%
AMGN
Amgen Inc.
3.6%10.9%
TFX
Teleflex Incorporated
3.3%2.4%
ABC
AmerisourceBergen Corporation
3.3%15%
TAK
Takeda Pharmaceutical Company Limited
3.2%12.7%
VEEV
Veeva Systems Inc.
3.1%13.4%
UHS
Universal Health Services, Inc.
3.1%11.2%
BSX
Boston Scientific Corporation
2.5%19.3%
MOH
Molina Healthcare, Inc.
2.5%16%
QGEN
Qiagen N.V.
2.2%5.5%
A
Agilent Technologies, Inc.
2.1%0.8%
BRKR
Bruker Corporation
2%16.4%
ABT
Abbott Laboratories
1.9%4.9%
BIO
Bio-Rad Laboratories, Inc.
1.8%2.8%
CAH
Cardinal Health, Inc.
1.8%-3.8%
HUM
Humana Inc.
1.7%11.3%
INSM
Insmed Incorporated
1.7%18.2%
ANTM
Elevance Health Inc.
1.7%6.6%
ELV
Elevance Health Inc.
1.7%6.6%
COO
The Cooper Companies, Inc.
1.6%9.8%
CHE
Chemed Corporation
1.6%7.4%
JNJ
Johnson & Johnson
1.6%5.2%
EHC
Encompass Health Corporation
1.6%12.7%
COR
Cencora
1.5%12.8%
TECH
Bio-Techne Corporation
1.4%9%
BMY
Bristol-Myers Squibb Company
1.3%8.4%
MTD
Mettler-Toledo International Inc.
1.2%11.8%
MEDP
Medpace Holdings, Inc.
1.2%7.7%
TEM
Tempus AI, Inc.
1.1%33%
CRL
Charles River Laboratories International, Inc.
1%-1.6%
DVA
DaVita Inc.
1%4.6%
GEHC
GE HealthCare Technologies Inc.
1%0.9%
BDX
Becton, Dickinson and Company
0.9%9.8%
BDXA
Becton, Dickinson and Company
0.9%9.8%
BDXB
Becton, Dickinson and Company
0.9%9.8%
MCK
McKesson Corporation
0.8%17.8%
IDXX
IDEXX Laboratories, Inc.
0.8%5.8%
STE
STERIS plc
0.7%-1.8%
EW
Edwards Lifesciences Corporation
0.6%-8.5%
BIIB
Biogen Inc.
0.5%2.9%
SOLV
Solventum Corporation
0.4%1.4%
ALGN
Align Technology, Inc.
0.4%4%
UNH
UnitedHealth Group Incorporated
0.3%8.1%
LH
Laboratory Corporation of America Holdings
0.3%9.8%
FMS
Fresenius Medical Care AG & Co. KGaA
-0.1%-3.6%
PKI
PerkinElmer, Inc.
-0.2%-42.3%
HQY
HealthEquity, Inc.
-0.2%20.5%
CNC
Centene Corporation
-0.2%3.4%
NBIX
Neurocrine Biosciences, Inc.
-0.4%24.7%
ZTS
Zoetis Inc.
-0.5%11%
NVS
Novartis AG
-0.8%15.1%
HOLX
Hologic, Inc.
-1%0.9%
ILMN
Illumina, Inc.
-1.1%-1.6%
ABBV
AbbVie Inc.
-1.3%3.8%
BLCO
Bausch + Lomb Corporation
-1.3%18.8%
GKOS
Glaukos Corporation
-1.3%23.9%
HCA
HCA Healthcare, Inc.
-1.5%7.9%
TMO
Thermo Fisher Scientific Inc.
-1.6%4.7%
THC
Tenet Healthcare Corporation
-1.6%1.1%
PEN
Penumbra, Inc.
-1.7%11.1%
GILD
Gilead Sciences, Inc.
-1.8%6.4%
GMED
Globus Medical, Inc.
-1.9%63.1%
LNTH
Lantheus Holdings, Inc.
-1.9%18.4%
RMD
ResMed Inc.
-2.1%10.3%
ATR
AptarGroup, Inc.
-2.2%1.1%
MRK
Merck & Co., Inc.
-2.5%4.4%
ABMD
Abiomed, Inc.
-2.8%7.2%
PFE
Pfizer Inc.
-3.2%24.7%
EXAS
Exact Sciences Corporation
-3.3%12.8%
REGN
Regeneron Pharmaceuticals, Inc.
-3.6%10.3%
RCM
R1 RCM Inc.
-3.6%14.7%
PHG
Koninklijke Philips N.V.
-4.4%-2.1%
DXCM
DexCom, Inc.
-4.5%2%
ALC
Alcon Inc.
-4.8%5.4%
VTRS
Viatris Inc.
-5%-5.2%
MESO
Mesoblast Limited
-5.1%-41.2%
RVTY
Revvity, Inc.
-5.1%4.8%
HSIC
Henry Schein, Inc.
-5.7%0.4%
IQV
IQVIA Holdings Inc.
-6.1%1.3%
CTLT
Catalent, Inc.
-6.2%4.2%
INCY
Incyte Corporation
-6.2%16.3%
BGNE
BeiGene, Ltd.
-8.5%28.2%
TEVA
Teva Pharmaceutical Industries Limited
-9.1%-5.1%
GSK
GSK plc
-9.2%-1.7%
HZNP
Horizon Therapeutics Public Limited Company
-9.5%7.8%
ICLR
ICON Public Limited Company
-10.6%-1.2%
SGEN
Seagen Inc.
-11.2%27.1%
ELAN
Elanco Animal Health Incorporated
-12.7%-3.6%
RXDX
Prometheus Biosciences, Inc.
-13.5%-71.8%
BPMC
Blueprint Medicines Corporation
-14.3%126.6%
EXEL
Exelixis, Inc.
-17.3%14.3%
ALNY
Alnylam Pharmaceuticals, Inc.
-19.1%-33.3%
SGFY
Signify Health, Inc.
-24.4%11.9%
PODD
Insulet Corporation
-27.2%-13.9%
BAX
Baxter International Inc.
-28.1%-27.2%
LEGN
Legend Biotech Corporation
-28.5%66.9%
ARGX
argenx SE
-29%73.8%
CERE
Cerevel Therapeutics Holdings, Inc.
-100%-
ZBH
Zimmer Biomet Holdings, Inc.
-100%-100%
KRTX
Karuna Therapeutics, Inc.
--100%
NUVL
Nuvalent, Inc.
--
PCVX
Vaxcyte, Inc.
--
RVMD
Revolution Medicines, Inc.
--
SMMT
Summit Therapeutics Inc.
--

Disclaimer

1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.

2. The information is not complete; for comprehensive data, please refer to the relevant websites.

3. All stock market data analyses are subject to survivorship bias.

warning